Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific biên lợi nhuận phân khúc (Segment Income Margin) — Specialty Diagnostics (%)
IR Financial Reconciliation Package & SEC MD&A
Latest, FY2025
26.9%
Period ended Dec 31, 2025
Change on a year earlier
+1.2 pts
25.7% in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biên lợi nhuận phân khúc (Segment Income Margin) — Specialty Diagnostics (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.9% | +1.2 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 25.7% | +0.2 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 25.5% | +4.0 pts | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 21.5% | -1.1 pts | SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗ |
| FY2021 | Dec 31, 2021 | 22.6% | – | SEC Form 10-K (10k_2022, filed 2023-02-23) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Biên lợi nhuận phân khúc (Segment Income Margin) — Specialty Diagnostics (%), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_margin_sd
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.